Ganga Pharmaceuticals Limited (BOM:539680)
12.00
0.00 (0.00%)
At close: Feb 12, 2026
Ganga Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Ganga Pharmaceuticals had annual revenue of 28.28M INR with 7.22% growth. Ganga Pharmaceuticals had revenue of 14.61M in the half year ending March 31, 2026, with 3.18% growth.
Revenue
28.28M
Revenue Growth
+7.22%
P/S Ratio
2.51
Revenue / Employee
1.66M
Employees
17
Market Cap
70.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 28.28M | 1.91M | 7.22% |
| Mar 31, 2025 | 26.37M | -984.21K | -3.60% |
| Mar 31, 2024 | 27.36M | 1.49M | 5.78% |
| Mar 31, 2023 | 25.86M | 973.18K | 3.91% |
| Mar 31, 2022 | 24.89M | 1.15M | 4.83% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.17B |
| Beryl Drugs | 215.51M |
| Fabino Enterprises | 208.41M |
| Brawn Biotech | 173.07M |
| Unjha Formulations | 152.79M |
| Decipher Labs | 138.51M |
| Desh Rakshak Aushdhalaya | 66.33M |
| Emmessar Biotech & Nutrition | 23.78M |
Ganga Pharmaceuticals News
- 3 months ago - Ganga Pharmaceuticals Quarterly report: H2 2026 - Filings
- 10 months ago - Ganga Pharmaceuticals Quarterly report: H1 2026 - Filings